Production (Stage)
BIOQUAL, Inc.
BIOQ
$43.19
-$0.25-0.58%
OTC PK
| 02/28/2025 | 11/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 23.15% | -3.19% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 23.15% | -3.19% | |||
| Cost of Revenue | -1.81% | 1.55% | |||
| Gross Profit | 2,505.55% | -125.98% | |||
| SG&A Expenses | -8.59% | 8.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.69% | 2.43% | |||
| Operating Income | 164.48% | -60.80% | |||
| Income Before Tax | 177.21% | -79.48% | |||
| Income Tax Expenses | 177.21% | -79.42% | |||
| Earnings from Continuing Operations | 177.21% | -79.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 177.21% | -79.51% | |||
| EBIT | 164.48% | -60.80% | |||
| EBITDA | 243.83% | -139.95% | |||
| EPS Basic | 177.22% | -79.51% | |||
| Normalized Basic EPS | 177.22% | -79.48% | |||
| EPS Diluted | 176.95% | -78.95% | |||
| Normalized Diluted EPS | 177.22% | -79.48% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 1.00% | -- | |||